Association of the C-propeptide of type II collagen with mineralization of embryonic chick long bone and sternal development.
Several proteins may play a role in bone formation. The C-propeptide of type II collagen is intimately associated with endochondral bone formation in bovine growth plate. We have used an antibody against this peptide to determine its immunofluorescent distribution in early stages of embryonic chick limb development with emphasis on first bone formation which occurs in the mid-diaphyseal region. The C-propeptide II is first evident by immunofluorescent localization at stage 27 (day 5-6) of embryonic tibia development with chondrocytes in the central mid-diaphysis. In subsequent stages, there is an increase in the number of chondrocytes in which it is localized in discrete vacuoles. Up to stage 30, immunofluorescence is observed intracellularly, after which it appears in the matrix. The released C-propeptide II appears to remain only transiently associated with the cartilage matrix and becomes concentrated in the calcifying periosteum, the region outside of the cartilage core where bone formation first occurs in a sequence of events comparable to intramembranous bone formation. These observations can be reproduced in cultures of stage 35 hypertrophic chondrocytes (core cells) and periosteum cells (collar cells). Core cells contain intensely stained intracellular vacuoles while collar cells are negative, although the collar cell osteogenic matrix concentrates exogenously added C-propeptide II. Double label immuno-staining shows that the C-propeptide II, unlike type II collagen and proteoglycan, which are secreted and incorporated into extracellular sites, is initially stored in intracellular vacuoles. The matrix localization of the C-propeptide II during the transition from cartilage to bone indicates a close association with the initiation of mineralization events of cartilage and bone and its specific origin in chondrocytes and not osteoblasts. These observations suggest that the C-propeptide II made by chondrocytes is associated with the formation of bone.
Kujawa
M J
MJ
Biology Department, Case Western Reserve University, Cleveland, Ohio 44106.
Weitzhandler
M
M
Poole
A R
AR
Rosenberg
L
L
Caplan
A I
AI
D000818:Animals; D000918:Antibody Specificity; D001846:Bone Development / Q000502:physiology*; D001842:Bone and Bones / Q000032:analysis / Q000166:cytology / Q000502:physiology*; D002113:Calcification, Physiologic / Q000187:drug effects / Q000502:physiology*; D002135:Calcium-Binding Proteins / Q000032:analysis / Q000276:immunology / Q000502:physiology*; D002356:Cartilage / Q000032:analysis / Q000502:physiology; D002642:Chick Embryo; D003094:Collagen / Q000032:analysis / Q000276:immunology / Q000502:physiology*; D024043:Collagen Type II; D005121:Extremities / Q000502:physiology; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D008875:Middle Aged; D013249:Sternum / Q000187:drug effects / Q000502:physiology*
D002135:Calcium-Binding Proteins; D024043:Collagen Type II; D007106:Immune Sera; C040072:chondrocalcin; D003094:Collagen